Drug Topics

AUGUST 2, 2023

Moderna’s mRNA-1273 vaccine was associated with a lower risk of diagnosed COVID-19 when compared to Pfizer’s BNT162b2.

Vaccines 187

Vaccines 187

Pharmacy Times

AUGUST 2, 2023

Study findings contrast with previously reported research linking aspirin to the secondary prevention of stroke, and are especially notable for older adults who may be more susceptible to bleeding-inducing events.

123

123

Drug Topics

AUGUST 2, 2023

Wildfire smoke is a considerable contributor to air pollution, with wildfire smoke exposure consistently associated with respiratory morbidity including lung cancer risk.

98

98

Pharmacy Times

AUGUST 2, 2023

The study authors said that, to their knowledge, this will be the first systemic review focusing on the effects of cognitive interventions for those with chronic respiratory diseases.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

AUGUST 2, 2023

A study from Bavaria, Germany, found the frequency was higher among boys and children younger than the median age of 6.5 years during the pandemic.

98

98

Pharmacy Times

AUGUST 2, 2023

Study investigators observed no significant differences in oxygen supplementation, hospitalization, or COVID-19 related death between initiators and non-initiators, though they cautioned more research was needed.

Hospitals 122

Hospitals 122

Pharmacy Times

AUGUST 2, 2023

With an intravenous immunoglobulin-based treatment protocol, individuals who underwent renal transplantation and who were presensitized achieved intermediate-term graft and recipient survival results at 98%.

121

121

STAT

AUGUST 2, 2023

Simon Matthews made three trips this spring to the emergency room of his local hospital in Eastbourne, on England’s southeast coast, before doctors managed to figure out what was making him so ill. He had a fever of 104 Fahrenheit, uncommonly high for an adult. On his first foray to the hospital — in an ambulance — it was feared he had meningitis.

Hospitals 98

Hospitals 98

Pharmacy Times

AUGUST 2, 2023

The approved assay can differentiate between infection of COVID-19, influenza, or respiratory syncytial virus, minimizing the need for multiple tests or physician visits.

FDA 123

FDA 123

Fierce Pharma

AUGUST 2, 2023

Intas Pharmaceuticals’ new warning letter from the U.S. FDA reads like a checklist of what not to do when the regulator pays a visit to your manufacturing facility. | The FDA handed Intas a five-observation write up after inspecting the company’s Sanand, India, production plant from November 22 to December 2, 2022. The company got dinged for lapses in quality control, incomplete lab records, testing shortfalls and more.

FDA 98

FDA 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

AUGUST 2, 2023

Reduced quality of life was observed in patients with hemophilia who were unemployed, had blood-borne illnesses, or had a high annual bleeding rate.

123

123

STAT

AUGUST 2, 2023

All great stories have complicated endings. But that doesn’t mean they can’t offer simple and instructive lessons. Christopher Nolan’s magnum opus , “Oppenheimer,” highlights the tragic story about the “father of the atomic bomb.” But it’s also a story about how the United States missed an opportunity to be a global leader in the development of an innovation that would define the 20 th century.

98

98

Pharmacy Times

AUGUST 2, 2023

In terms of science and technology, the health care community has everything needed to clinically implement pharmacogenomics testing.

123

123

Fierce Healthcare

AUGUST 2, 2023

Informa Markets has struck a deal with the Healthcare Information and Management Systems Society (HIMSS) to acquire one of the largest health IT conferences in the market. | Informa Markets, a division of the business-to-business publishing and events company Informa PLC, will take on management of the HIMSS Exhibition, while HIMSS will continue to oversee developing expert content and programming, the organizations announced Tuesday.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

AUGUST 2, 2023

A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.

Immunization 123

Immunization Vaccines 123

Fierce Pharma

AUGUST 2, 2023

In the latest clash of the vaccine titans, GSK is locking horns with Pfizer over claims the company’s competing respiratory syncytial virus (RSV) shot Abrysvo treads on patents belonging to its own | GSK says Pfizer’s vaccine RSV vaccine Abrysvo—approved in late May—infringes four patents related to its RSV antigen shot Arexvy, which itself snagged a green light in the U.S. earlier that same month.

Vaccines 98

Vaccines 98

Pharmacy Times

AUGUST 2, 2023

Medical experts discuss clinical, social, and economic obstacles limiting pneumococcal vaccination efforts.

Vaccines 122

Vaccines 122

STAT

AUGUST 2, 2023

I should be irate and despondent about the Supreme Court’s scrapping of affirmative action in admissions. It’s several steps backward. And yet, I have mixed emotions about the practice, informed by my own experiences with affirmative action.

98

98

Fierce Pharma

AUGUST 2, 2023

Teva has long maintained its innocence in the face of a far-reaching price-fixing indictment by the U.S. Department of Justice (DOJ). | Teva has long maintained its innocence in the face of a far-reaching price-fixing indictment by the U.S. Department of Justice. Now, the company is earmarking a sizable chunk of cash in an attempt to put the charges to bed.

98

98

STAT

AUGUST 2, 2023

Both Humana and CVS Health on Wednesday touted plans to aggressively scale their primary care clinics for seniors and funnel Medicare members into those clinics. It’s a formula that’s been mastered by UnitedHealth Group, which is both the country’s largest Medicare Advantage insurer and one of the biggest physician employers. Even so, investors signaled they think Humana and CVS can catch up, sending both companies’ stock prices higher after their respective second qu

Insurance 98

Insurance 98

Drug Store News

AUGUST 2, 2023

A report from the Senior Care Pharmacy Coalition and ATI Advisory features case studies of three LTC pharmacies that offer different service models to home-based patients in various markets.

98

98

STAT

AUGUST 2, 2023

Roughly 7.7% of Americans didn’t have any health insurance as of this past March — a “record low” uninsured rate, according to the latest health insurance survey from the Centers for Disease Control and Prevention. However, that uninsured rate — which still translated to more than 25 million Americans with no health coverage — is almost certainly higher now.

Insurance 98

Insurance 98

European Pharmaceutical Review

AUGUST 2, 2023

A new COVID-19 vaccine has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). Bimervax is now the ninth vaccine to be authorised by the UK’s independent medicines regulator to treat the virus. MHRA authorisation of Bimervax The COVID-19 vaccine, developed by HIPRA Human Health, combines a part of the SARS-CoV-2 virus spike protein with an adjuvant, according to the MHRA.

Vaccines 98

Vaccines Immunization 98

Fierce Healthcare

AUGUST 2, 2023

Duke University Health System has tapped Microsoft to support its exploration of generative AI and cloud technologies, the academic system announced this week. | The organizations aim to roll out a secure cloud ecosystem across Duke Health and—with a focus on ethics and health equity—leverage generative AI for new healthcare applications.

98

98

Hospital Pharmacy Europe

AUGUST 2, 2023

Taldefgrobep alfa has been given orphan medicinal product designation from the European Commission (EC) for the treatment of spinal muscular atrophy (SMA). A novel anti-myostatin adnectin, the drug has the potential to deliver significant benefits for people with SMA by enhancing muscle function when used in combination with currently available disease modifying therapies that help preserve motor neurons.

Hospitals 98

Hospitals 98

Fierce Pharma

AUGUST 2, 2023

The convenience of shorter infusion time is a big selling point for TG Therapeutics’ newly FDA-approved multiple sclerosis drug Briumvi. | The convenience of shorter infusion time is a big selling point for TG Therapeutics’ newly FDA-approved multiple sclerosis drug Briumvi. But an under-the-skin version of Roche’s well-established Ocrevus could pose a threat to TG’s lone offering.

FDA 97

FDA 97

Fierce Healthcare

AUGUST 2, 2023

Higher volumes and revenues weren’t enough to keep Community Health Systems (CHS) from a $38 million net loss (-$0.29 per diluted share) for the second quarter, according to financial results for t | The for-profit's leadership pointed to sequential improvements in key metrics like patient volumes and net operating revenues, but ultimately stayed in the red for another quarter.

97

97

STAT

AUGUST 2, 2023

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

97

97

Fierce Pharma

AUGUST 2, 2023

Eight years after an initial FDA approval in heavily pretreated colorectal cancer, Taiho Oncology’s Lonsurf has won another green light in the same indication but as part of a more powerful regimen | Eight years after an initial FDA approval in heavily pretreated colorectal cancer, Taiho Oncology’s Lonsurf has won another green light in the same indication but as part of a more powerful regimen.

FDA 97

FDA 97

Fierce Healthcare

AUGUST 2, 2023

Humana’s flourishing Medicare Advantage numbers didn’t slow down in the second quarter, leading the Louisville-based insurer to again raise its 2023 membership expectations and maintain an upbeat d | The insurer beat the street with a nearly 40% year-over-year increase in net income and a 13% bump in revenue. Executives also highlighted MA membership growth they said will fuel the company over the next few years.

Insurance 97

Insurance 97

Fierce Pharma

AUGUST 2, 2023

During a first-quarter earnings call, as CEO Chris Viehbacher talked of his plan to return Biogen to growth, he said the company needed to figure out the best way to manage its biosimilar business | During a first-quarter earnings call, Biogen CEO Chris Viehbacher said the company needed to figure out the best way to manage its biosimilar business and determine who might be its “best owner.

97

97

European Pharmaceutical Review

AUGUST 2, 2023

Research published in Biotechnology and Bioengineering has demonstrated two innovative, automatic, online, real-time sample acquisition and preparation systems for in-process monitoring, control, and release of biopharmaceuticals. The proposed autonomous process analytical technology (PAT) platform comprises of a micro sequential injection (µSI) process analyser and automatic assay preparation platform (A2P2) for use in the laboratory as an off-line analytical system and on the manufacturing flo

97

97

Drug Store News

AUGUST 2, 2023

Each pre-measured sheet can be used in a regular or short wash cycle in cold, warm or hot water and is dissolved completely with no residue left behind, the company said.

98

98

Drug Topics

AUGUST 2, 2023

Drug Topics spoke with Peter Koo, PharmD, RPh at McKesson ideaShare 2023 about the launch of Foster & Thrive.

98

98